Innovative Approaches to Increase Access to Medicines in Developing Countries

по Hilde Stevens, Isabelle Huys
Опубликовано 2017-12-01

An overview of patents on therapeutic monoclonal antibodies in Europe: are they a hurdle to biosimilar market entry?

по Evelien Moorkens, Arnold G. Vulto, Isabelle Huys
Опубликовано 2020-01-01

Time Investment in Drug Supply Problems by Flemish Community Pharmacies

по Elfi De Weerdt, Steven Simoens, Minne Casteels, Isabelle Huys
Опубликовано 2017-08-01

Stakeholder Perspectives on Access and Benefit-Sharing for Areas Beyond National Jurisdiction

по Jane Eva Collins, Jane Eva Collins, Thomas Vanagt, Isabelle Huys
Опубликовано 2020-05-01

Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium

по Liese Vandeborne, Eline van Overbeeke, Marc Dooms, Birgit De Beleyr, Isabelle Huys
Опубликовано 2019-05-01

Real-World Evidence Gathering in Oncology: The Need for a Biomedical Big Data Insight-Providing Federated Network

по Tine Geldof, Tine Geldof, Isabelle Huys, Walter Van Dyck, Walter Van Dyck
Опубликовано 2019-03-01

Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany

по Evelien Moorkens, Teresa Barcina Lacosta, Arnold G. Vulto, Martin Schulz, Gabriele Gradl, Salka Enners, Gisbert Selke, Isabelle Huys, Steven Simoens
Опубликовано 2020-10-01

Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains

по Christine Rohde, Grégory Resch, Jean-Paul Pirnay, Bob G. Blasdel, Laurent Debarbieux, Daniel Gelman, Andrzej Górski, Ronen Hazan, Isabelle Huys, Elene Kakabadze, Małgorzata Łobocka, Alice Maestri, Gabriel Magno de Freitas Almeida, Khatuna Makalatia, Danish J. Malik, Ivana Mašlaňová, Maia Merabishvili, Roman Pantucek, Thomas Rose, Dana Štveráková, Hilde Van Raemdonck, Gilbert Verbeken, Nina Chanishvili
Опубликовано 2018-04-01